Effectiveness of ibrutinib as first‐line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab‐bendamustine: Results of study on 486 cases outside clinical trials. Issue 8 (3rd May 2021)

• Record Type: Journal Article
• Authors: Morabito, Fortunato; Tripepi, Giovanni; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Bossio, Sabrina; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Visentin, Andrea; Condoluci, Adalgisa; Moia, Riccardo; Pietrasanta, Daniela; Loseto, Giacomo; Consoli, Ugo; Scortechini, Ilaria; Rossi, Francesca Maria; Zucchetto, Antonella; Al‐Janazreh, Hamdi; Vigna, Ernesto; Martino, Enrica Antonia; Cassin, Ramona; D′Arrigo, Graziella; Galimberti, Sara; Rago, Angela; Angeletti, Ilaria; Biagi, Annalisa; Del Giudice, Ilaria; Bomben, Riccardo; Neri, Antonino; Fronza, Gilberto; Monti, Paola; Menichini, Paola; Olivieri, Jacopo; Cutrona, Giovanna; Rossi, Davide; Cuneo, Antonio; Di Raimondo, Francesco; Gaidano, Gianluca; Polliack, Aaron; Trentin, Livio; Foà, Robin; Ferrarini, Manlio; Gattei, Valter; Gentile, Massimo;
• Is Part Of: American journal of hematology. Volume 96:Issue 8(2021)
• Page Start: E269
• Page End: E272
• Publication Date: 2021-05-03
• Subjects: Hematology -- Periodicals; 616.15
• DOI: 10.1002/ajh.26201
• Languages: English
• ISSNs: 0361-8609